Pulmonology · Medical Literature
Airway Mucus Occlusions in Ex-Smokers with and Without COPD.
Abstract
In patients with moderate-to-severe COPD, airway mucus-occlusions correlate with airflow limitation, exacerbation and mortality-risk. However, the clinical relevance of mucus-plugs in milder COPD is not well-understood. We evaluated pulmonary function, six-minute-walk-distance (6MWD), emphysema and airway mucus-plugs at baseline and 31 ± 7 months later (follow-up), in ex-smokers with COPD, and those at risk of COPD, but with normal spirometry. Ninety-three ex-smokers with (n = 54) and without COPD (n = 39) underwent spirometry, plethysmography, the six-minute-walk-test (6MWT),129Xe MRI, and CT at a baseline visit and 31 ± 7 months later. Baseline and follow-up FEV1, FVC, RV/TLC, DLCO, mucus-score, -count, -volume, -length, airway wall-thickness%, total-airway-count (TAC), relative-area-of-lung-with-attenuation ≤-950 Hounsfield Units (RA950), and 129Xe MRI ventilation-defect-percent (VDP) were measured. A Sankey plot was generated to follow mucus-plug dynamics at follow-up. At follow-up, there was significantly worse 6MWD, RV/TLC (COPD, p ≤ 0.04), VDP, CT RA950, airway WT% and TAC in participants with (p ≤ 0.002) and without COPD (p ≤ 0.03), but there was no change in FEV1, mucus-score, count, volume or length (all p > 0.07). At baseline, there were 289 plugs in 58 participants; at FU, 94/289 (33%) mucus-plugs persisted and there were 193 new plugs for a total of 287 mucus-plugs (Δmucus-score = 0, p = 0.7; Δmucus-count = -2, p = 0.5). In COPD and participants at-risk for COPD, there was significantly worse airway remodelling, emphysema, gas-trapping, exercise capacity, and ventilation defects. While two thirds of plugs resolved, new plugs, in new locations were observed at follow-up; mucus-count and score did not change. The temporal dynamics of mucus-plugs should be considered when evaluating their clinical relevance in COPD patients.Clinical Trial Registration: www.clinicaltrials.gov NCT02279329.
Clinical relevance
In ex-smokers with COPD (including milder disease) and those at risk for COPD with normal spirometry, do airway mucus-plug burden, pulmonary function, exercise capacity, and structural lung measures change over approximately 31 months of follow-up? __SNAPSHOT__ {"studyDesign":"Prospective longitudinal observational cohort study with paired baseline and follow-up assessments","setting":"Single academic research institution (Robarts Research Institute, Western University, London, Canada); tertiary/academic setting","sampleSize":"n = 93 (COPD: n = 54; at-risk ex-smokers with normal spirometry: n = 39)","population":"Ex-smokers with confirmed COPD (spirometry-defined) and ex-smokers at risk for COPD but with normal spirometry at baseline; full severity spectrum not specified beyond 'milder COPD' context","intervention":"Serial multimodal phenotyping including spirometry, body plethysmography, DLCO, 6-minute walk test (6MWT), ¹²⁹Xe hyperpolarized gas MRI (ventilation defect percent [VDP]), and CT (mucus-plug scoring, airway wall thickness %, total airway count [TAC], and RA950 for emphysema) at baseline and at 31 ± 7 months","comparator":"Within-subject comparison (baseline vs. follow-up); between-group comparison of COPD vs. at-risk ex-smokers with normal spirometry","primaryOutcome":"Change in mucus-plug burden (mucus score, count, volume, length) and pulmonary structure-function measures (FEV1, FVC, RV/TLC, DLCO, VDP, RA950, airway WT%, TAC) from baseline to follow-up; 6MWD as exercise capacity endpoint","followUp":"31 ± 7 months","fundingSource":"Not reported (authors declared no funding associated with this work; senior author disclosed speaking honoraria and prior study funding from GSK, AZ, Sanofi-Regeneron, Trudell Medical — disclosed as potential conflicts but not as funding for this specific study)"}
Key findings
At approximately 31 months of follow-up, significant worsening was observed across multiple structural and functional domains in both groups. In participants with COPD, 6MWD, RV/TLC (p ≤ 0.04), ¹²⁹Xe MRI VDP, CT RA950, airway wall thickness %, and total airway count all worsened significantly (p ≤ 0.002). Participants without COPD (at-risk, normal spirometry) also showed significant worsening in these same measures (p ≤ 0.03), suggesting early subclinical disease progression even before spirometric COPD criteria are met. Notably, FEV1 did not change significantly in either group (p > 0.07), reinforcing that spirometry may be insensitive to early or intermediate structural disease progression. Mucus-plug burden as measured by mucus score, count, volume, and length did not change significantly (all p > 0.07; Δmucus-score = 0, p = 0.7; Δmucus-count = −2, p = 0.5). However, mucus plug dynamics were highly variable: of 289 plugs identified at baseline across 58 participants, only 94/289 (33%) persisted at follow-up, while 193 new plugs appeared in new locations, yielding a total of 287 plugs at follow-up. This pattern of near-complete plug turnover (approximately two-thirds resolved, with equivalent new plug formation) demonstrates that aggregate mucus burden scores are stable at the group level despite substantial individual plug-level dynamism. Absolute and relative effect sizes, confidence intervals, and NNT/NNH were not reported in the available abstract.
Practice implications
This study establishes that in ex-smokers — both those with established COPD and those with normal spirometry but at risk for COPD — significant worsening of airway remodelling, emphysema, gas-trapping, exercise capacity, and ventilation heterogeneity occurs over approximately 2.5 years, even in the absence of detectable FEV1 decline. This finding is clinically important: it underscores that spirometry alone may miss meaningful longitudinal disease progression and that multimodal imaging (CT + ¹²⁹Xe MRI) captures pathophysiological deterioration invisible to standard lung function testing. The mucus plug dynamics data are particularly instructive — a static, single-timepoint mucus score may misclassify the true burden or trajectory of mucus disease, as approximately two-thirds of plugs resolve between assessments while new plugs emerge in different airway segments. Clinicians should therefore interpret a negative mucus score at any single visit with caution, as it does not exclude prior or future plugging. The study does not establish causality between mucus dynamics and outcomes, nor does it quantify the prognostic risk attributable to mucus plug turnover versus persistent plugging in this milder-disease population. Findings likely apply to ex-smokers with mild-to-moderate COPD or pre-COPD states; populations with severe COPD, current smokers, non-smokers, and those with significant comorbidities were not well-represented or were excluded. Since only the abstract was available for this review, granular data including effect sizes, confidence intervals, subgroup analyses, and full covariate adjustment details are not assessable — a critical limitation of this summary. __LIMITATIONS__ Small sample size (n = 93 total) limits statistical power for subgroup analyses and generalizability.,Single academic center in Canada limits external validity to other healthcare systems and ethnicities.,Only ex-smokers were included; findings may not apply to current smokers or never-smokers with airway disease.,¹²⁹Xe MRI is not widely available in routine clinical practice, limiting immediate translational applicability.,Mucus-plug scoring relied on trained observer consensus reading of CT (semi-quantitative, not AI-automated), introducing potential inter-rater variability; however, dual-observer consensus was used to mitigate this.,FEV1-based spirometry confirmed prior findings of insensitivity to longitudinal change in this population, but absence of post-bronchodilator spirometry details and full GOLD staging data limits severity characterization.,Follow-up of 31 ± 7 months may be insufficient to detect FEV1 decline or mucus-plug-driven outcomes such as exacerbations or mortality in a mild/pre-COPD cohort.,No adjustment for interim therapy changes, exacerbations, or respiratory infections during follow-up is described in the abstract — significant confounders of both mucus burden and lung function trajectories.,Aggregate stability of mucus scores may mask clinically important inter-individual variability in plug dynamics; individual-level predictors of plug persistence vs. resolution were not reported.,No funding was declared, which, while reassuring, also raises questions about resource constraints affecting sample size and follow-up duration.,Only the abstract was available for this review; full methodology, statistical models, covariate adjustment, and complete results tables cannot be evaluated. __BOTTOM_LINE_CATEGORY__ potentially_practice_informing __BOTTOM_LINE__ In ex-smokers with and without COPD, approximately 31 months of follow-up revealed significant worsening of airway remodelling, emphysema, gas-trapping, exercise capacity, and ventilation defects by CT and ¹²⁹Xe MRI — even in those with normal spirometry — while FEV1 and aggregate mucus-plug burden scores remained unchanged, highlighting spirometry's insensitivity to early structural progression. Critically, mucus plug dynamics were highly fluid: roughly two-thirds of baseline plugs resolved and were replaced by new plugs in different segments, so a single-timepoint mucus score should not be interpreted as reflecting stable or absent mucus disease. These findings support the use of multimodal imaging for longitudinal disease monitoring in at-risk ex-smokers, but confirmation in larger, multicenter cohorts is needed before changing clinical practice.